Elsevier

Clinical Immunology

Volume 145, Issue 1, October 2012, Pages 55-58
Clinical Immunology

LETTER TO THE EDITOR
Role of SNAP29, LZTR1 and P2RXL1 genes on immune regulation in a patient with atypical 0.5 Mb deletion in 22q11.2 region

https://doi.org/10.1016/j.clim.2012.07.013Get rights and content

Introduction

Chromosome 22q11.2 deletion syndrome (22q11.2DS) is found in a heterogeneous group of disorders sharing a common genetic basis with an estimated incidence of 1:4000 live births. The majority of patients with DiGeorge syndrome (DGS) and velo-cardio-facial syndrome (VCFS) have monosomic deletions of chromosome 22q11.2 [1]. The patients suffering from the 22q11.2DS have a common proximal breakpoint, and in 90% of patients it produces a 3 Mb deletion (typical deleted region) while in 7% of patients it produces a 1.5 Mb deletion [2]. The majority of patients with 22q11.2DS and immune defects exhibit mild to moderate deficits in T-cell numbers [3].

In 2007, D'Angelo et al. [4] reported on a molecular diagnosis of a female patient with obesity, hyperphagia, and aggressive behavior, and who had a major depressive disorder. These authors reported an atypical 1 Mb microdeletion in the 22q11.2 region, detected using the Multiplex Ligation-dependent Probe Amplification (MLPA) assay.

Therefore, the aim of this investigation was to perform a subsequent investigation using an SNP-array technique in order to better define the rearrangement and investigate the presence of other genomic imbalances in this patient. Furthermore, considering that immunological studies were not performed by D'Angelo et al. [4] we evaluate the humoral and cellular response of this rare case of atypical deletion of chromosome 22q11.2.

Section snippets

Current clinical evaluation

Currently, the patient is 13 years old and on physical examination, the OFC was 57 cm (> 95th centile), height was 147 cm (< 25th centile), and weight was 122.3 kg (> 97th centile). The patient presents with hyperphagia, obesity, non-alcoholic steatohepatitis and chronic otitis media. Compulsive food eating and behavioral problems had worsened progressively. She started on antipsychotic medication to control aggressiveness and required a special education program. The patient's routine laboratory

Discussion

The risk of immunodeficiency is commonly observed in 22q11.2DS, as in patients with DGS/VCFS. However, no published studies have reported the immunological aspects of patients with atypical deletions of chromosome 22q11.2. We have conducted a study in a patient with atypical 0.5 Mb 22q11.2 deletion involving SNAP29, LZTR1, and P2RXL1 genes. The patient has elevated absolute values of T cells, TCD4+, TCD8+ and total leucocytes with an inverted CD4+/CD8+ ratio, suggesting a lymphoproliferative

Conclusion

Our results indicate that patients with a 0.5 Mb deletion in the 22q11.2 region have an immune response different from that found in patients with the typical 22q11.2DS (e.g. DGS), which is manifested as a cellular or combined immunodeficiency. Moreover, the present study suggests that SNAP29, LZTR1 and P2RXL1 genes, involved in an atypical 22q11.2 deletion, are crucial in immune regulation, particularly on expression of T, B, NK and NKT cells.

Conflict of interest statement

The author(s) declare that there are no conflicts of interest.

Acknowledgments

The authors thank the patient, their families and FAPESP (number 2010/52694-8) for financial support.

References (10)

There are more references available in the full text version of this article.

Cited by (6)

  • Snapshots from within the cell: Novel trafficking and non trafficking functions of Snap29 during tissue morphogenesis

    2023, Seminars in Cell and Developmental Biology
    Citation Excerpt :

    Similarly, seizures have been observed in 36% of CEDNIK patients to date, suggesting that epilepsy might be a frequent consequence of reduced SNAP29 activity. A heterozygous 1 Mb microdeletion in 22q11.2, involving SNAP29, LZTR1 and P2RXL1, has also been reported in a patient with obesity, hyperphagia, aggressive behavior, major depressive disorder and immune deficiency [103,104]. While it is interesting to note again the occurrence of psychiatric disorders in association with a loss of SNAP29, it is not clear whether heterozygous loss of function of SNAP29 might cause the emergence of any trait.

  • Central 22q11.2 deletions

    2014, American Journal of Medical Genetics, Part A
View full text